Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Opiant Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +7 vs. Q3 2021
- Shares held
- 1.42M
- +146.4K (+11.5%) vs. Q3 2021
- Total value
- $47.6M
- +$14.9M (+45.7%) vs. Q3 2021
- New holders
- 11
- 11 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 224,297 | $7.54M | 0.00% | −23,195−9.4% | Reduced |
| Renaissance Technologies LLC | 183,815 | $6.18M | 0.01% | −21,800−10.6% | Reduced |
| Vanguard Group Inc | 178,459 | $6.00M | 0.00% | +40,689+29.5% | Added |
| Apis Capital Advisors, LLC | 110,000 | $3.70M | 4.10% | +8,000+7.8% | Added |
| Two Sigma Advisers, LP | 82,400 | $2.77M | 0.01% | −700−0.8% | Reduced |
| Acadian Asset Management LLC | 71,916 | $2.42M | 0.01% | +7,475+11.6% | Added |
| Dimensional Fund Advisors LP | 66,651 | $2.24M | 0.00% | +22,543+51.1% | Added |
| Two Sigma Investments, LP | 64,057 | $2.15M | 0.01% | +13,012+25.5% | Added |
| Geode Capital Management, LLC | 50,244 | $1.69M | 0.00% | 00.0% | Unchanged |
| EAM Investors, LLC | 44,771 | $1.51M | 0.25% | −24,275−35.2% | Reduced |
| Northern Trust Corp | 37,850 | $1.27M | 0.00% | −48−0.1% | Reduced |
| BlackRock Inc. | 34,744 | $1.17M | 0.00% | +10,058+40.7% | Added |
| Morgan Stanley | 34,336 | $1.15M | 0.00% | +18,547+117.5% | Added |
| Perritt Capital Management Inc | 32,000 | $1.08M | 0.56% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 31,291 | $1.05M | 0.24% | +1,291+4.3% | Added |
| Essex Investment Management Co LLC | 31,263 | $1.05M | 0.12% | +6,471+26.1% | Added |
| DLD Asset Management, LP | 30,000 | $1.01M | 0.09% | +30,000 | New |
| Marshall Wace, LLP | 23,577 | $793.0K | 0.00% | +23,577 | New |
| Bailard, Inc. | 16,242 | $546.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 12,000 | $404.0K | 0.00% | +12,000 | New |
| Bridgeway Capital Management, LLC | 10,400 | $350.0K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,125 | $273.0K | 0.00% | +1,800+28.5% | Added |
| Bank of New York Mellon Corp | 7,803 | $262.0K | 0.00% | +7,803 | New |
| JPMorgan Chase & Co | 6,743 | $227.0K | 0.00% | +5,584+481.8% | Added |
| Cubist Systematic Strategies, LLC | 6,417 | $216.0K | 0.00% | +6,417 | New |
| Marquette Asset Management, LLC | 5,180 | $174.0K | 0.04% | −2,761−34.8% | Reduced |
| Hillsdale Investment Management Inc. | 3,200 | $108.0K | 0.01% | +3,200 | New |
| Dorsey Wright & Associates | 2,138 | $72.0K | 0.01% | +2,138 | New |
| Newbridge Financial Services Group, Inc. | 1,850 | $62.0K | 0.03% | −300−14.0% | Reduced |
| Royal Bank of Canada | 1,200 | $40.0K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 500 | $17.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $17.0K | 0.00% | 00.0% | Unchanged |
| TAP Consulting, LLC | 471 | $16.0K | 0.00% | +471 | New |
| UBS Group AG | 305 | $10.0K | 0.00% | −133−30.4% | Reduced |
| American Research & Management Co. | 300 | $10.0K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 266 | $9.00K | 0.00% | +266 | New |
| Bank of America Corp | 252 | $8.00K | 0.00% | −13−4.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 180 | $6.05K | 0.00% | 00.0% | Unchanged |
| Retirement Planning Co of New England, Inc. | 180 | $6.00K | 0.00% | +180 | New |
| National Bank of Canada | 100 | $3.00K | 0.00% | +100 | New |
| Federated Hermes, Inc. | 63 | $2.00K | 0.00% | 00.0% | Unchanged |
| Sage Private Wealth Group, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Rothschild & Co Wealth Management UK Ltd | 0 | $0 | 0.00% | −1,419−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −366−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |